54.00p+1.50 (+2.86 %)23 Nov 2020, 16:43
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Diurnal Group PLC Market & Company News

23.11.2020 07:00 Exercise of Options, Issue of Equity and TVRRNS
20.11.2020 12:06 Result of Annual General MeetingRNS
20.11.2020 07:00 Grant of European Patent for AlkindiRNS
10.11.2020 07:00 Notice of Interim ResultsRNS
02.11.2020 16:47 Holding(s) in CompanyRNS
30.10.2020 11:34 Holding(s) in CompanyRNS
30.10.2020 08:37 Holding(s) in CompanyRNS
29.10.2020 10:30 Holding(s) in CompanyRNS
29.10.2020 09:25 Director DealingsRNS
28.10.2020 12:49 Result of General Meeting and Open OfferRNS
21.10.2020 06:00 MAA for Alkindi submitted to SwissmedicRNS
19.10.2020 06:00 Vesting of LTIP awardsRNS
09.10.2020 09:37 Result of Placing, Open Offer and Notice of GMRNS
09.10.2020 06:00 Proposed Placing and Open OfferRNS
08.10.2020 13:28 Posting of Annual Report and AGM NoticeRNS
30.09.2020 15:41 Second Price Monitoring ExtnRNS
30.09.2020 15:35 Price Monitoring ExtensionRNS
30.09.2020 06:00 Alkindi Sprinkle approved by US FDARNS
15.09.2020 06:00 Results for the year ended 30 June 2020RNS
03.09.2020 16:33 Holdings in CompanyRNS
03.09.2020 06:00 Two further marketing and distribution agreementsRNS
19.08.2020 09:00 Notice of Full Year ResultsRNS
13.08.2020 13:06 Second Price Monitoring ExtnRNS
13.08.2020 13:00 Price Monitoring ExtensionRNS
10.08.2020 08:14 Holding(s) in CompanyRNS
10.08.2020 06:00 Alkindi approved in AustraliaRNS
05.08.2020 06:00 Alkindi approved in IsraelRNS
30.07.2020 15:41 Second Price Monitoring ExtnRNS
30.07.2020 15:35 Price Monitoring ExtensionRNS
30.07.2020 13:06 Second Price Monitoring ExtnRNS
30.07.2020 13:00 Price Monitoring ExtensionRNS
30.07.2020 10:05 Second Price Monitoring ExtnRNS
30.07.2020 10:00 Price Monitoring ExtensionRNS
30.07.2020 06:01 Business and trading updateRNS
30.07.2020 06:00 Positive DITEST Regulatory Meeting with US FDARNS
29.07.2020 15:41 Second Price Monitoring ExtnRNS
29.07.2020 15:36 Price Monitoring ExtensionRNS
15.07.2020 12:04 Director DealingsRNS
13.07.2020 12:29 Director Dealings and Issue of EquityRNS
13.07.2020 12:28 Grant of Deferred Share AwardsRNS
26.06.2020 13:29 Director DealingsRNS
09.06.2020 06:00 Chronocort Phase 3 data at ENDO Online 2020RNS
29.05.2020 06:00 Change of AdviserRNS
30.04.2020 08:05 Second Price Monitoring ExtnRNS
30.04.2020 08:00 Price Monitoring ExtensionRNS
21.04.2020 09:05 Director Dealings and Issue of EquityRNS
16.04.2020 13:23 Director DealingsRNS
15.04.2020 15:41 Second Price Monitoring ExtnRNS
15.04.2020 15:36 Price Monitoring ExtensionRNS
15.04.2020 06:00 Operational UpdateRNS
06.04.2020 08:21 Director DealingsRNS
01.04.2020 06:00 Chronocort MAA Passes Validation Stage with EMARNS
30.03.2020 17:18 Holding(s) in CompanyRNS
27.03.2020 17:26 Holding(s) in CompanyRNS
27.03.2020 09:17 Director DealingsRNS
27.03.2020 07:00 US Licencing Agreement with Eton PharmaceuticalsRNS
26.03.2020 14:05 Second Price Monitoring ExtnRNS
26.03.2020 14:00 Price Monitoring ExtensionRNS
25.03.2020 14:47 Result of General Meeting and Issue of EquityRNS
20.03.2020 16:48 Second Price Monitoring ExtnRNS
20.03.2020 16:39 Price Monitoring ExtensionRNS
06.03.2020 16:55 Result of Placing and Notice of General MeetingRNS
06.03.2020 11:22 Proposed PlacingRNS
05.03.2020 16:41 Directorate ChangeRNS
25.02.2020 15:06 Holding(s) in CompanyRNS
20.02.2020 16:41 Second Price Monitoring ExtnRNS
20.02.2020 16:36 Price Monitoring ExtensionRNS
20.02.2020 11:00 Price Monitoring ExtensionRNS
17.02.2020 13:46 Holding(s) in CompanyRNS
13.02.2020 07:00 US FDA Accepts NDA Application for AlkindiRNS
11.02.2020 07:00 Interim ResultsRNS
20.01.2020 07:00 Business and trading updateRNS
13.01.2020 07:00 Holding(s) in CompanyRNS
13.01.2020 07:00 Notice of Interim ResultsRNS
10.01.2020 15:45 Director Dealings and Issue of EquityRNS
10.01.2020 15:44 Issue of Long-Term Incentive Plan awardsRNS
16.12.2019 11:46 Director DealingsRNS
16.12.2019 07:00 Chronocort MAA Submitted in EuropeRNS
02.12.2019 14:28 Share Option Exercise and Issue of EquityRNS
02.12.2019 07:01 Holding(s) in CompanyRNS
02.12.2019 07:00 Alkindi New Drug Application Submitted to US FDARNS
26.11.2019 10:42 Director Dealings and Issue of EquityRNS
21.11.2019 13:08 Results of Annual General MeetingRNS
21.11.2019 07:00 AGM StatementRNS
20.11.2019 07:00 Successful outcome of testosterone clinical studyRNS
08.11.2019 07:00 Vesting of LTIP awardsRNS
21.10.2019 17:23 Issue of EquityRNS
21.10.2019 12:09 Director DealingsRNS
08.10.2019 10:26 Posting of Annual Report and AGM NoticeRNS
24.09.2019 06:00 Results for the year ended 30 June 2019RNS
07.08.2019 10:04 Director DealingsRNS
05.08.2019 11:27 Director/PDMR ShareholdingRNS
26.07.2019 15:32 Holding(s) in CompanyRNS
08.07.2019 13:07 Director Dealings and Issue of EquityRNS
03.07.2019 06:00 Market Authorisation Application in AustraliaRNS
26.06.2019 14:57 Holding(s) in CompanyRNS
24.06.2019 08:39 Director DealingsRNS
21.06.2019 14:40 Holding(s) in CompanyRNS
21.06.2019 14:35 Holding(s) in Company - ReplacementRNS
21.06.2019 09:18 Change of AuditorRNS
Showing 1 to 100 of 1,000